Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amylyx Pharmaceuticals, Inc. - Common Stock
(NQ:
AMLX
)
3.320
-0.070 (-2.06%)
Streaming Delayed Price
Updated: 9:55 AM EDT, Oct 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amylyx Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
January 26, 2024
There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains
Via
InvestorPlace
3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024
January 21, 2024
These top-rated biotech stocks are going to be in high demand in January and in every other month in 2024.
Via
InvestorPlace
7 Healthcare Stocks Taking Medicine to the Next Level
January 14, 2024
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider.
Via
InvestorPlace
2 Biotech Stocks With Huge Catalysts in 2024
January 05, 2024
Important clinical-trial readouts on the way could send these stocks soaring in early 2024.
Via
The Motley Fool
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
November 28, 2023
Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies.
Via
InvestorPlace
Earnings Preview For Amylyx Pharma
November 08, 2023
Via
Benzinga
Expert Ratings for Amylyx Pharma
August 11, 2023
Via
Benzinga
A Preview Of Amylyx Pharma's Earnings
August 09, 2023
Via
Benzinga
Why Shares of Amylyx Pharmaceuticals Were Up Monday
July 24, 2023
The company got a bump from an analyst's upgrade.
Via
The Motley Fool
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via
Benzinga
Amylyx Crashes 26% As New ALS Drug Faces A Barrage Of Troubles
November 09, 2023
The company says patient discontinuations mounted in the quarter.
Via
Investor's Business Daily
4 Analysts Have This to Say About Amylyx Pharma
July 24, 2023
Via
Benzinga
7 Analysts Have This to Say About Amylyx Pharma
May 31, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Amylyx Pharma
May 15, 2023
Via
Benzinga
Analyst Expectations for Amylyx Pharma's Future
May 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 09, 2023
Via
Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2023
October 19, 2023
These three lesser-known biotech companies are profitable and growing revenue.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2023
Via
Benzinga
2 Incredible Growth Stocks Near 52-Week Lows to Buy Now
October 10, 2023
These two high-tech bio companies may be too cheap to ignore right now.
Via
The Motley Fool
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
August 28, 2023
Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.
Via
InvestorPlace
3 Biotech Stocks to Buy Before Drug Trials End
July 28, 2023
Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.
Via
InvestorPlace
Amylyx Stock Has A Good Entry Point, Says Bullish Goldman Sachs
July 24, 2023
Shares of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) jumped in early trading on Monday, after remaining broadly flat last week.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
July 24, 2023
Via
Benzinga
EMA's Advisory Panel Gives Thumbs Down To Amylyx Pharma's Amyotrophic Lateral Sclerosis Treatment
June 23, 2023
The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a negative opinion regarding Amylyx Pharmaceuticals Inc's (NASDAQ: AMLX) conditional marketing authorization...
Via
Benzinga
Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics?
June 13, 2023
Which of these red-hot biotech stocks is the better buy right now?
Via
The Motley Fool
How Biohaven Is Coming 'Out Of Stealth Mode' — And Bullishly Extending A 4-Day Run
June 01, 2023
Shares surged into and out of the company's R&D Day, which included a surprise.
Via
Investor's Business Daily
2 Supercharged Growth Stocks to Buy Right Now
May 14, 2023
These two biopharma stocks might be poised for a major breakout.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
May 12, 2023
Via
Benzinga
US Stock Futures Signal Strong Finish To Wobbly Week — But Analyst Still Sees Recession Risk On Horizon
May 12, 2023
Via
Benzinga
Amylyx Blows Past Sales Expectations, Reports Unexpected Profit — Shares Rocket
May 11, 2023
The company was expected to post another loss, but instead came in with a gain of 2 cents per share.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.